Clinical Trials
5
Active:0
Completed:4
Trial Phases
2 Phases
Phase 2:1
Not Applicable:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Not Applicable
4 (80.0%)Phase 2
1 (20.0%)Multi-Center Study of Panosyl-Isomaltooligosaccharides Adjunctive to PPI Therapy to Treat GERD
- First Posted Date
- 2022-09-27
- Last Posted Date
- 2025-07-11
- Lead Sponsor
- Microbiome Health Sciences
- Target Recruit Count
- 156
- Registration Number
- NCT05556824
- Locations
- 🇺🇸
Elite Clinical Studies LLC, Phoenix, Arizona, United States
🇺🇸Wr-Msra, Llc, Lake City, Florida, United States
🇺🇸A Positive Clinical Research, Miami, Florida, United States
Tolerability Study of Panosyl-Isomaltooligosaccharides (PIMO) and a Placebo in Subjects With Heartburn
Not Applicable
Completed
- Conditions
- Heartburn
- First Posted Date
- 2022-05-06
- Last Posted Date
- 2023-07-18
- Lead Sponsor
- Microbiome Health Sciences
- Target Recruit Count
- 211
- Registration Number
- NCT05363618
- Locations
- 🇺🇸
Microbiome Health Sciences, Manassas, Virginia, United States
Tolerability Study of Panosyl Isomaltooligosaccharides (PIMO), in Subjects With Chronic Idiopathic Constipation (CIC)
Not Applicable
Completed
- Conditions
- Constipation Chronic Idiopathic
- First Posted Date
- 2021-11-22
- Last Posted Date
- 2023-07-18
- Lead Sponsor
- Microbiome Health Sciences
- Target Recruit Count
- 172
- Registration Number
- NCT05129618
- Locations
- 🇺🇸
Remote Study - by phone and online, Manassas, Virginia, United States
Open Label Tolerability Study of ISOThrive Prebiotic Nectar (MIMO) in Subjects With Constipation
Not Applicable
Completed
- Conditions
- Constipation
- First Posted Date
- 2020-12-21
- Last Posted Date
- 2022-05-05
- Lead Sponsor
- ISOThrive Inc.
- Target Recruit Count
- 106
- Registration Number
- NCT04677634
- Locations
- 🇺🇸
ISOThrive Inc., Manassas, Virginia, United States
Tolerability Study of a Novel Microbiome Therapeutic in Subjects With Gastroesophageal Reflux Disease
Not Applicable
Completed
- Conditions
- Gastroesophageal Reflux
- First Posted Date
- 2020-07-29
- Last Posted Date
- 2021-08-30
- Lead Sponsor
- ISOThrive Inc.
- Target Recruit Count
- 156
- Registration Number
- NCT04491734
- Locations
- 🇺🇸
ISOThrive Inc., Manassas, Virginia, United States
News
No news found